GlassScriptPhysician profile
Hillary Winkler
NPI 1205601440
$4,258.18
in general payments reported to CMS, 2019-2025
23 companies · $2,728 in 2025
The $2,728 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $15.98 · 2024: $1,514 · 2025: $2,728.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,158 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,158.19 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $887.70 | 2024-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $433.17 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $413.46 | 2024-2025 | Dupixent, Libtayo |
| Genzyme Corporation | $333.36 | 2024-2025 | |
| Incyte Corporation | $325.00 | 2024-2025 | Opzelura, Opzelura |
| Boehringer Ingelheim Pharmaceuticals, INC. | $256.55 | 2024-2025 | Spevigo |
| Sun Pharmaceutical Industries INC. | $217.91 | 2024-2025 | |
| Abbvie INC. | $214.73 | 2025 | |
| Lilly USA, LLC | $167.37 | 2023-2025 | Taltz, Ebglyss, Olumiant |
| Amgen INC. | $159.36 | 2024-2025 | Otezla, Otezla |
| Organogenesis INC. | $146.73 | 2025 | Affinity, Puraply Wound Matrix, Cygnus Dual |
| Galderma Laboratories, L.P. | $107.68 | 2024-2025 | Aklief, Nemluvio |
| Leo Pharma INC. | $100.05 | 2025 | Adbry |
| E.R. Squibb & Sons, L.L.C. | $92.13 | 2024-2025 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $73.24 | 2024-2025 | Zoryve |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $54.22 | 2024-2025 | Bimzelx |
| Springworks Therapeutics, INC. | $50.82 | 2025 | Gomekli |
| Organon LLC | $44.86 | 2025 | Vtama |
| Dermavant Sciences, INC. | $44.24 | 2024 | Vtama |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $40.57 | 2024-2025 | Cabtreo, Arazlo, Jublia |
| Kyowa Kirin, INC. | $40.19 | 2024 | Poteligeo |
| Lnhc, INC | $32.28 | 2025 | Zelsuvmi |
| Almirall LLC | $22.56 | 2025 | Klisyri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hillary Winkler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.